EVOQUE System for Heart Valve Replacement
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Edwards Lifesciences · Industry
This trial is looking for patients who need a special heart procedure called transcatheter tricuspid valve replacement. Participants will receive the EVOQUE system and will need to attend follow-up appointments to see how they are doing.
You may be able to join if
- I am suitable for the EVOQUE system treatment as decided by the heart team.
- I agree to attend follow-up assessments.
- I have given written consent to take part in this study.
You may not be able to join if
- I am currently in another clinical study for a treatment.
- I am considered part of a vulnerable population.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis is a prospective, single-arm, multi-center, real-world study of an the Edwards EVOQUE system.
Loading trial locations…